Welcome to Art therapy Guide
Goals And Objectives Of Art Therapy Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
BACP Art Therapy Provisions
from:The British Association for Counselling and Psychotherapy, or BACP, is today's professional membership association for UK's counselors and psychotherapists, a branch of the Standing Conference for the Advancement of Counselling. Originally it included only counseling, but in September of 2000 it branched out to include psychotherapy with the BACP name change from the British Association for Counselling. It was here that the BACP Art Therapy came into effect on the psychotherapy level for accepted professionalism.
Art psychotherapy uses visual expression as a form of therapy that can effect the mental, emotional, or behavioral disorders of disturbed individuals of all ages, gender, and background. To apply for BACP membership for accreditation as a BACP art therapy professional, requires qualification from a BACP art therapy accredited training course in addition to a minimum of 450 hours of supervised practice. Mandatory is 450 hours with 150 of them must be subsequent to the training completion from three to six-years. Or alternatively, the individual can be awarded a admittance from a BACP accredited training course.
A certain amount of criteria must be met before an individual can become accepted through the BACP Art Therapy in the psychotherapy division, and this criteria is met by following certain things.
• The individual is a member of BACP, and will remain so for the accreditation period. Requirements must be met to maintain the accreditation.
• The individual is covered by professional indemnity insurance.
• The individual is in practice as a professional at the time of the application.
• Training and supervised practice is provided and followed.
BACP Art Therapy plays an active part in the Faculty for Healthcare Counsellors and Psychotherapists (FHCP), as a major subsidiary organization of the BACP. With close to 2,000 members, it is the largest membership organization that is entirely associated with healthcare counselors and psychotherapist. With similar goals, both BACP and FHCP promote and support the patient's choice of psychological therapy, along with accessible services. Their members are competent and efficient, while the organization trains and provides opportunities for their prospective counselors, such as art therapist, by providing training events and conferences.
Another division of the BACP is the Association for Independent Practitioners, or AIP, for those who are interested in the BACP Art Therapy membership but more on an independent level. Formerly the Personal Relationship Groupwork (PRG), it involves those who choose to work independently rather than within a professional group. In this region, there is more of an emphasis on clear boundaries, and provisions of support and supervision. Members from other groups and cultures are actively invited to join this group, as a part of their philosophic practices.
Goals And Objectives Of Art Therapy News
Astellas & AVEO: Tivozanib Successfully Demonstrates the Longest Reported Progression-Free Survival in First Line ...
Astellas Pharma Europe Ltd. and AVEO Oncology confirmed today that tivozanib, a novel once-daily oral tyrosine kinase inhibitor , successfully achieved its prim
Read more...Theravance Reports First Quarter 2012 Financial Results
SOUTH SAN FRANCISCO, Calif. -- Theravance, Inc. reported today its financial results for the quarter ended March 31, 2012. Revenue for the first quarter of 2012 was $127.1 million. Net income for the first ...
Read more...Envision Pharmaceutical Services Awarded Virginia Premier Health Plan PBM Services Contract
Virginia Premier Health Plan and Envision Pharmaceutical Services, Inc., today announced a multi-year agreement that establishes Envision as the exclusive provider of pharmacy benefit management services for Virginia Premier’s 150,000 managed Medicaid members starting 7/1/2012.
Read more...Significant Improvement in Disability Scores Observed in Multiple Sclerosis Patients Who Received LemtradaTM ...
Genzyme, a Sanofi company , reports today additional data from the Phase III CARE-MS II trial. Accumulation of disability was significantly slowed in patients with multiple sclerosis who were treated with alemtuzumab versus Rebif® , as measured by the Expanded Disability Status Scale , a standard assessment of physical disability progression.
Read more...HBIO Reports First Quarter 2012 Revenue Growth of 8% Over First Quarter 2011
HOLLISTON, Mass. -- Harvard Bioscience, Inc. , a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited ...
Read more...